CureVac N.V. Overview

CureVac N.V. Research & Development

Research & Development expenses for CVAC.

Quarterly R&D Expenses

$-49979000.00

As of Nov 30, 2025

Annual R&D Expenses (TTM)

$66.63M

↓ 50.96% YoY

Trailing 12 months ending Nov 30, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin